CWEGF yields 36.30% · JNJ yields 2.13%● Live data
📍 CWEGF pulled ahead of the other in Year 1
Combined, CWEGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWEGF + JNJ for your $10,000?
Crew Energy Inc. engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGL) in Canada. It primarily holds interests in Septimus, West Septimus, Groundbirch/Monias, Tower, and Attachie, areas located in the southwest, south, and west of Fort St. John in British Columbia. As of December 31, 2021, the West Septimus area had proved plus probable reserves of 51,559.2 thousand barrels (Mbbl) of NGL and 893,110 million cubic feet (Mmcf) of conventional natural gas; the Septimus area comprised of proved plus probable reserves of 4,257.6 Mbbl of light and medium crude oil, and 11,568.9 Mbbl of NGL along with 368,407 Mmcf of conventional natural gas; the Groundbirch/Monias area had total proved plus probable reserves of 9,500.5 Mbbl of NGL and 461,168 Mmcf of conventional natural gas; the Tower area comprised proved plus probable reserves of 1,599.2 Mbbl of light and medium crude oil, 619.2 Mbbl of NGL, and 23,364 Mmcf of conventional natural gas; and the Attachie area comprised proved plus probable reserves of 6,753.4 Mbbl of NGL and 164,970 Mmcf of conventional natural gas The company was incorporated in 2003 and is headquartered in Calgary, Canada.
Full CWEGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.